Aclairo Pharmaceutical Development Group Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 27

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Aclairo Pharmaceutical Development Group General Information

Description

Provider of consulting and regulatory services catering to healthcare, pharmaceutical and drug-device industries. The company offers regulatory services, preclinical project management, scientific writing, preclinical ADME, IND preparation, CTD/eCTD maintenance, gap analyses, toxicology, pharmacology, and NDA/MAA preparation, enabling providing clients with strategic, scientific regulatory services, and operations support.

Contact Information

Website
www.aclairo.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 45600 Terminal Drive
  • Suite 200
  • Sterling, VA 20166
  • United States
+1 (571)
Primary Industry
Consulting Services (B2B)
Other Industries
Other Healthcare Services
Parent Company
Experimental Pathology Laboratories
Corporate Office
  • 45600 Terminal Drive
  • Suite 200
  • Sterling, VA 20166
  • United States
+1 (571)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aclairo Pharmaceutical Development Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aclairo Pharmaceutical Development Group‘s full profile, request access.

Request a free trial

Aclairo Pharmaceutical Development Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of consulting and regulatory services catering to healthcare, pharmaceutical and drug-device industries. The co
Consulting Services (B2B)
Sterling, VA
27 As of 2025

Durham, NC
 

Huntsville, AL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aclairo Pharmaceutical Development Group Competitors (2)

One of Aclairo Pharmaceutical Development Group’s 2 competitors is BioAgilytix Labs, a Private Equity-Backed company based in Durham, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAgilytix Labs Private Equity-Backed Durham, NC
Discovery Life Sciences Private Equity-Backed Huntsville, AL
You’re viewing 2 of 2 competitors. Get the full list »

Aclairo Pharmaceutical Development Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aclairo Pharmaceutical Development Group FAQs

  • When was Aclairo Pharmaceutical Development Group founded?

    Aclairo Pharmaceutical Development Group was founded in 2004.

  • Where is Aclairo Pharmaceutical Development Group headquartered?

    Aclairo Pharmaceutical Development Group is headquartered in Sterling, VA.

  • What is the size of Aclairo Pharmaceutical Development Group?

    Aclairo Pharmaceutical Development Group has 27 total employees.

  • What industry is Aclairo Pharmaceutical Development Group in?

    Aclairo Pharmaceutical Development Group’s primary industry is Consulting Services (B2B).

  • Is Aclairo Pharmaceutical Development Group a private or public company?

    Aclairo Pharmaceutical Development Group is a Private company.

  • What is Aclairo Pharmaceutical Development Group’s current revenue?

    The current revenue for Aclairo Pharmaceutical Development Group is .

  • Who are Aclairo Pharmaceutical Development Group’s competitors?

    BioAgilytix Labs and Discovery Life Sciences are competitors of Aclairo Pharmaceutical Development Group.

  • When was Aclairo Pharmaceutical Development Group acquired?

    Aclairo Pharmaceutical Development Group was acquired on 13-Jan-2016.

  • Who acquired Aclairo Pharmaceutical Development Group?

    Aclairo Pharmaceutical Development Group was acquired by Experimental Pathology Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »